Talis Biomedical $32.5M Securities Class Action Settlement

If you purchased or acquired common stock issued by Talis Biomedical Corporation between February 11, 2021, and August 11, 2021, you may be eligible to claim compensation from a class action settlement.

Talis Biomedical Corporation has agreed to pay $32,500,000 to settle a class action lawsuit for alleged misstatements and omissions regarding their Talis One diagnostic platform.

Who can claim compensation?

To be eligible to claim compensation, you must meet the following criteria:

• Purchased or acquired Talis common stock between February 11, 2021, and August 11, 2021
• Purchased stock pursuant to the registration statement and prospectus issued for the initial public offering on February 11, 2021
• Suffered losses as a result of these transactions

The class members eligible to file a claim include:

• Individuals or entities that purchased or acquired Talis common stock during the specified period
• Those who purchased stock pursuant to the registration statement and prospectus issued for the initial public offering
• Members who suffered damages as a result of these transactions

How much can class members get?

The settlement provides a fund of $32,500,000 to be distributed among eligible class members. The amount each member can receive depends on the number of valid claims submitted and the details of their transactions.

• Recognized Loss Amounts: Calculated based on the purchase price, sale price, and the number of shares involved.
• Pro Rata Distribution: The net settlement fund will be divided among all valid claimants based on their recognized claims.

For example, if the net settlement fund is $30,000,000 and the total recognized claims are $60,000,000, each claimant would receive 50% of their recognized claim.

How to file a claim

To claim an award, class members must submit a claim form by March 13, 2025. They can file a claim online or download the PDF claim form and mail it to _Talis Biomedical Corporation Securities Litigation, c/o A.B. Data, Ltd., P.O. Box 173064, Milwaukee, WI 53217_.

Claimants need to provide documentation such as broker confirmations or stockbroker statements to verify their transactions in Talis common stock.

Claim instructions

1. Gather all necessary documentation of your Talis stock transactions.
2. Complete the claim form with accurate details.
3. Submit the form online or mail it to the provided address.
4. Ensure submission by the deadline.

Payment methods

Class members can receive payments via:

• PayPal
• Virtual debit card
• Paper check

$32.5 Million settlement fund

The settlement fund of $32,500,000 will cover:

• Payments to eligible class members.
• Attorneys' fees not exceeding 28% of the settlement amount.
• Litigation expenses up to $1,800,000.
• An award to the lead plaintiff not exceeding $37,500.

Important dates

• Deadline to File a Claim: March 13, 2025
• Final Approval Hearing: March 14, 2025

When is the Talis Biomedical Securities Settlement payout date?

The court will hold a final approval hearing on March 14, 2025. If approved, the settlement will be distributed to eligible claimants who submitted valid claims by the deadline.